Key facts
- This page summarizes Melissa Orilall's Form 3 filing for MiNK Therapeutics, Inc. (INKT).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Apr 2026, 16:15.
Melissa Orilall - 13 Mar 2026 Form 3 Insider Report for MiNK Therapeutics, Inc. (INKT)
- Reporting relationship
- Principal Financial Officer
- Issuer ticker
- INKT
- Reported as of
- 13 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- By: /s/ Melissa Orilall
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Melissa Orilall filed Form 3 for MiNK Therapeutics, Inc. (INKT) on 09 Apr 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002125307
Primary reporting owner
Orilall Melissa
- Relationship
- Principal Financial Officer
- Address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK
- Signature
- By: /s/ Melissa Orilall
- Signature date
- 09 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INKT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 222
- Date
- 13 Mar 2026
- Ownership
- By spouse
* marks a reported price that did not pass the local price check.